Skip to main content
Log in

CD28 proximal promoter polymorphisms in systemic lupus erythematosus susceptibility

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

CD28 expression and serum levels are significantly increased in patients with SLE than in healthy controls (HC). Until now, there are no studies of proximal promoter polymorphisms of CD28 gene in SLE. Therefore, our objective was to investigate the polymorphisms present in the proximal promoter of CD28 in a group of SLE and HC and to associate the polymorphisms present with the CD28 serum levels of 40 patients and 40 controls. One hundred and seven patients as well as 108 controls matched by age range and genders were included. The 11 ACR criteria were analyzed on the clinical files, and the proximal promoter region of CD28 gene was analyzed by direct sequencing of a 489-basepair fragment. C28 serum levels (sCD28) were measured by ELISA technique in 40 patients and 40 controls. Only two of the eight reported polymorphisms were found, and they correspond to rs35593994 (−372 A/G) and rs56156157 (−145 −/C). The first had a prevalence of 41 and 36% in patients and controls respectively and the second of 1.4% in both groups. None of these polymorphisms were associated with SLE, and the polymorphism −372 A/G was not associated with the clinical features of disease. Likewise, the association with the sCD28 and the genotypes of −372 A/G polymorphism was not significant. The polymorphisms of the proximal promoter of CD28 are not associated with SLE, and the polymorphism −372 A/G is not associated with the diagnostic criteria of SLE or the sCD28.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kaneko H, Saito K, Hashimoto H, Yagita H, Okumura K, Azuma M (1996) Preferential elimiantion of CD28+ T cells in systemic lupus erythematosis (SLE) and the relation with activation-induced apoptosis. Clin Exp Immunol 106:218–229

    Article  PubMed  CAS  Google Scholar 

  2. Wong CK, Lit LCW, Tam LS, Li EK, Lam CWK (2005) Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology 44:989–994

    Article  PubMed  CAS  Google Scholar 

  3. Hebbar M, Jeannin P, Magistrelli G, Hatron PY, Hachulla E, Devulder B et al (2004) Detection of circulating soluble CD28 in patients with lupus erythematosus, primary Sjögren syndrome and systemic sclerosis. Clin Exp Immunol 136:388–392

    Article  PubMed  CAS  Google Scholar 

  4. Alvarado C, Alcocer-Varela J, Llorente L, Richaud-Patin Y, Cerbon M, Alarcon-Segovia D (1994) Effect of CD28 antibody on T cells from patients with systemic lupus erythematosus. J Autoimmun 7:763–773

    Article  PubMed  CAS  Google Scholar 

  5. Miyagawa H, Yamai M, Sakaguchi D, Kiyohara C, Tsukamoto H, Kimoto Y et al (2008) Association of polymorphisms in complement C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology 47:158–164

    Article  PubMed  CAS  Google Scholar 

  6. Teutsch SM, Booth DR, Bennetts BH, Heard RN, Stewart GJ (2004) Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients. J Neuroimmunol 148:218–230

    Article  PubMed  CAS  Google Scholar 

  7. Tan PL, Borman GB, Wigley RD (1981) Testing clinical criteria for systemic lupus erythematosus in other connective tissue disorders. Rheumatol Int 1:147–149

    Article  PubMed  CAS  Google Scholar 

  8. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215

    Article  PubMed  CAS  Google Scholar 

  9. The U.S. National library of medicine and the Nationals institutes of Health. CD28 SNP, Homo sapiens. Retrieved 2 April 2010, www.ncbi.nlm.nih.gov

  10. Brambila-Tapia AJ, Gámez-Nava JI, Salazar-Páramo M, Muñoz-Valle JF, González-López L, Llamas-Covarrubias MA, et al (2010) Increased CD28 serum levels are not associated with specific clinical activity in systemic lupus erythematosus. Rhematol Int Apr 14

  11. Lin CJ, Tam RC (2001) Transcriptional regulation of CD28 expression by CD28GR, a novel promoter element located in exon 1 of the CD28 gene. J Immunol 166:6134–6143

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ingrid P. Dávalos-Rodríguez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brambila-Tapia, A.J.L., Dávalos-Rodríguez, I.P., Gámez-Nava, J.I. et al. CD28 proximal promoter polymorphisms in systemic lupus erythematosus susceptibility. Rheumatol Int 32, 2165–2168 (2012). https://doi.org/10.1007/s00296-011-1942-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-011-1942-7

Keywords

Navigation